טוען...
Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy
BACKGROUND: Proliferative diabetic retinopathy (PDR) is a complication of diabetic retinopathy that can cause blindness. Although panretinal photocoagulation (PRP) is the treatment of choice for PDR, it has secondary effects that can affect vision. An alternative treatment such as anti‐vascular endo...
שמור ב:
| הוצא לאור ב: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley & Sons, Ltd
2014
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6995643/ https://ncbi.nlm.nih.gov/pubmed/25418485 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD008721.pub2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|